JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zampolli, A.
Right arrow Articles by De Caterina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zampolli, A.
Right arrow Articles by De Caterina, R.

Vol. 295, Issue 2, 818-823, November 2000

Inhibition of Endothelial Cell Activation by Nitric Oxide Donors1

Antonella Zampolli, Giuseppina Basta, Guido Lazzerini, Martin Feelisch2 and Raffaele De Caterina3

Consiglio Nazionale delle Ricerche Institute of Clinical Physiology Laboratory for Thrombosis and Vascular Research, Pisa, Italy

Because nitric oxide (NO) inhibits the expression of endothelial leukocyte adhesion molecules, NO-generating compounds have major therapeutic potential for use outside their classical indications. We report on the in vitro potential antiatherogenicity of two novel cysteine-containing NO donors, SP/W 3672, a fast spontaneous NO releaser, and its prodrug SP/W 5186, which liberates NO after bioactivation. The ability of these two compounds to inhibit monocyte adhesion and surface expression of endothelial adhesion molecules was evaluated and compared with that of other NO donors. SP/W 5186 and SP/W 3672 inhibited the adhesion of U937 monocytes to cultured human endothelial cells more potently than S-nitrosoglutathione (GSNO) or spermine NONOate, whereas nitroglycerin and isosorbide dinitrate were ineffective at comparable concentrations. A similar rank order of potency was found for the inhibition of expression of the adhesion molecules vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin as well as for major histocompatibility complex class II antigen expression. Estimated IC50 values for vascular cell adhesion molecule-1were >400 µM for SP/W 4744 (control for SP/W 3672 lacking the cysteine moiety), 200 µM for GSNO and spermine NONOate, 80 µM for SP/W 3672, and 50 µM for SP/W 5186. Moreover, SP/W 5186 inhibited VCAM-1 mRNA levels more potently than GSNO. This effect was likely to be transcriptional because mRNA degradation was not affected. In conclusion, SP/W 3672 and SP/W 5186 are novel potent inhibitors of endothelial activation, and this effect appears to relate to their ability to liberate NO for prolonged periods of time, either spontaneously or after conversion to active hydrolytic products.


1 This work was partially funded through research grants from the Italian National Research Council (Consiglio Nazionale delle Ricerche, CNR) to the CNR Institute of Clinical Physiology, Laboratory for Thrombosis and Vascular Research, Pisa, Italy, and by a travel grant to R.D.C. by Schwarz Pharma AG, Monheim, Germany.

2 Present address: Louisiana State University Health Sciences Center, Department of Molecular and Cellular Physiology, Shreveport, LA 71130-3932.

3 Present affiliation: "G. d'Annunzio" University, Chieti, Italy.


0022-3565/00/2952-0818$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
CirculationHome page
J.-P. Bin, A. Doctor, J. Lindner, E. M. Hendersen, D. E. Le, H. Leong-Poi, N. G. Fisher, J. Christiansen, and S. Kaul
Effects of Nitroglycerin on Erythrocyte Rheology and Oxygen Unloading: Novel Role of S-Nitrosohemoglobin in Relieving Myocardial Ischemia
Circulation, May 30, 2006; 113(21): 2502 - 2508.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. S. Kim, S. J. Son, E. K. Kim, S. N. Kim, D. G. Yoo, H. S. Kim, S. W. Ryoo, S. D. Lee, K. Irani, and B. H. Jeon
Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells
Cardiovasc Res, February 1, 2006; 69(2): 520 - 526.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Braam, R. de Roos, H. Bluyssen, P. Kemmeren, F. Holstege, J. A. Joles, and H. Koomans
Nitric Oxide-Dependent and Nitric Oxide-Independent Transcriptional Responses to High Shear Stress in Endothelial Cells
Hypertension, April 1, 2005; 45(4): 672 - 680.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Braam, R. de Roos, A. Dijk, P. Boer, J. A. Post, P. P. C. W. Kemmeren, F. C. P. Holstege, H. A. R. Bluysen, and H. A. Koomans
Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1977 - H1986.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Fiorucci, E. Distrutti, A. Mencarelli, G. Rizzo, A. R. D. Lorenzo, M. Baldoni, P. del Soldato, A. Morelli, and J. L. Wallace
Cooperation between Aspirin-Triggered Lipoxin and Nitric Oxide (NO) Mediates Antiadhesive Properties of 2-(Acetyloxy)benzoic Acid 3-(Nitrooxymethyl)phenyl Ester (NCX-4016) (NO-Aspirin) on Neutrophil-Endothelial Cell Adherence
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1174 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. De Caterina and C. Manes
Inflammation in early atherogenesis: impact of ACE inhibition
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24.
[Abstract] [PDF]


Home page
J. Immunol.Home page
R. A. Skidgel, X.-p. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik
Nitric Oxide Stimulates Macrophage Inflammatory Protein-2 Expression in Sepsis
J. Immunol., August 15, 2002; 169(4): 2093 - 2101.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.